CLINICAL_TRIALS
trial_result
· 2026-03-13
Clinical Trial Update: 3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions
Summary
3-year follow-up results from a clinical trial evaluating Jetstream combined with Ranger for calcified femoropopliteal lesions in peripheral artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Association de Provence pour la Promotion de l'Enseignement et la Recherche Cardiologique | Conditions: Peripheral Artery Disease | Status: COMPLETED | Results posted: 2026-03-13